The anti-infective action of a new steroid-base combination (fluclorolone acetonide in FAPG base) without conventional antimicrobial substances

Abstract
A double-blind trial comparing 0.025% fluclorolone acetonide in FAPG base with 0.1% betamethasone-17-valerate plus 0.5% neomycin has been carried out in 54 patients suffering from skin disease which, in the physician's opinion, required treatment with a topical steroid plus anti-infective agent. Clinical and bacteriological equivalency of the two products has been demonstrated.

This publication has 1 reference indexed in Scilit: